Paula Soteropoulos, Director of Dianthus Therapeutics DNTH, has filed 0 purchases and 7 sales on the open market. Over the past 12 months that comes to a net sale of $2.3M. The latest trade was on 05/21.

PS

PS

Paula Soteropoulos

Director

Company

Dianthus Therapeutics DNTH

First filing

23/01/20

Trades

24 trades

Buys / sales

0 / 7

12-month net buying

−$2.3M

Last trade

05/21

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Dianthus TherapeuticsDNTH	Open-market sale10b5-1 plan	05/08	05/11	599 sh	$85.47	$51,196.53	−100.0%
Dianthus TherapeuticsDNTH	Open-market sale10b5-1 plan	03/31	04/01	599 sh	$80.11	$47,985.89	−100.0%
Dianthus TherapeuticsDNTH	Open-market sale10b5-1 plan	03/24	03/26	27,594 sh	$78.05	$2,153,711.7	−100.0%
uniQureQURE	Open-market sale	24/06/13	24/06/17	2,220 sh	$5.14	$11,410.8	−9.9%
uniQureQURE	Open-market sale	23/06/16	23/06/20	2,275 sh	$18.99	$43,202.25	−9.2%
uniQureQURE	Open-market sale	23/02/27	23/03/01	384 sh	$19.97	$7,668.48	−2.3%
uniQureQURE	Open-market sale	23/01/18	23/01/20	6,000 sh	$22.59	$135,540	−26.8%